Back to Work

Roger Perlmutter is to take the helm of Merck's research and development branch, the Wall Street Journal reports. Previously, Perlmutter was the executive vice president of research and development at Amgen until his retirement about a year ago and prior to joining Amgen he was worked in basic research at Merck. "By hiring Dr.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.